{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:32:30Z","timestamp":1791311550578,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jns.2009.04.023","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T08:37:19Z","timestamp":1242290239000},"page":"81-85","source":"Crossref","is-referenced-by-count":74,"title":["Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice"],"prefix":"10.1016","volume":"286","author":[{"given":"Seema","family":"Tiwari-Woodruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda R.","family":"Voskuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.04.023_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","article-title":"Grey matter pathology in multiple sclerosis","volume":"64","author":"Vercellino","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib3","first-page":"285","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"Confavreux","year":"1998","journal-title":"Pregnancy in Multiple Sclerosis Group. N Engl J Med"},{"key":"10.1016\/j.jns.2009.04.023_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11910-002-0087-1","article-title":"Gender issues and multiple sclerosis","volume":"2","author":"Voskuhl","year":"2002","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jns.2009.04.023_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.52.6.1230","article-title":"Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis","volume":"52","author":"Kim","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.04.023_bib6","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains","volume":"166","author":"Bebo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.04.023_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2174\/1381612003399725","article-title":"Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS","volume":"6","author":"Cyr","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jns.2009.04.023_bib9","doi-asserted-by":"crossref","first-page":"s391","DOI":"10.2741\/1070","article-title":"Estrogen and Parkinson's disease","volume":"8","author":"Kompoliti","year":"2003","journal-title":"Front Biosci"},{"key":"10.1016\/j.jns.2009.04.023_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jsbmb.2007.09.011","article-title":"Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain","volume":"108","author":"Morissette","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jns.2009.04.023_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4049\/jimmunol.167.1.542","article-title":"Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice","volume":"167","author":"Ito","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.04.023_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jnr.1183","article-title":"17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis","volume":"65","author":"Matejuk","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2009.04.023_bib13","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/S0002-9440(10)63516-X","article-title":"The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha","volume":"163","author":"Polanczyk","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jns.2009.04.023_bib14","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.170.3.1548","article-title":"Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system","volume":"170","author":"Subramanian","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.04.023_bib15","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.4049\/jimmunol.171.12.6936","article-title":"Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease","volume":"171","author":"Liu","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.04.023_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneuroim.2003.11.004","article-title":"Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"146","author":"Palaszynski","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2009.04.023_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/en.142.3.969","article-title":"Minireview: neuroprotective effects of estrogen\u2014new insights into mechanisms of action","volume":"142","author":"Wise","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jns.2009.04.023_bib18","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1523\/JNEUROSCI.0453-06.2006","article-title":"Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis","volume":"26","author":"Morales","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2009.04.023_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0303-7207(03)00255-7","article-title":"Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression","volume":"206","author":"Harrington","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jns.2009.04.023_bib20","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1021\/jm010254a","article-title":"Estrogen receptor-beta potency-selective ligands: structure\u2013activity relationship studies of diarylpropionitriles and their acetylene and polar analogues","volume":"44","author":"Meyers","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.jns.2009.04.023_bib21","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.0703783104","article-title":"Differential neuroprotective and anti-inflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment","volume":"104","author":"Tiwari-Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2009.04.023_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1677\/joe.1.06063","article-title":"Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands","volume":"185","author":"Elloso","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jns.2009.04.023_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.expneurol.2004.01.015","article-title":"Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation","volume":"187","author":"Heikkinen","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib24","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1523\/JNEUROSCI.20-23-08604.2000","article-title":"Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory","volume":"20","author":"Leranth","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2009.04.023_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/ENDO:21:1:43","article-title":"Endogenous estrogen formation is neuroprotective in model of cerebellar ataxia","volume":"21","author":"Sierra","year":"2003","journal-title":"Endocrine"},{"key":"10.1016\/j.jns.2009.04.023_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jnr.20622","article-title":"Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats","volume":"82","author":"Sribnick","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2009.04.023_bib27","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Espeland","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.jns.2009.04.023_bib28","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jns.2009.04.023_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/71548","article-title":"Autoimmune encephalomyelitis ameliorated by AMPA antagonists","volume":"6","author":"Smith","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2009.04.023_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/brain\/awh156","article-title":"Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis","volume":"127","author":"Kanwar","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2009.04.023_bib31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI33464","article-title":"Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis","volume":"118","author":"Basso","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2009.04.023_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.410370403","article-title":"Sodium channel blockade by antibodies: a new mechanism of neurological disease?","volume":"37","author":"Waxman","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib33","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1152\/jn.00434.2003","article-title":"Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo","volume":"90","author":"Lo","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jns.2009.04.023_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ncpneuro0735","article-title":"Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis\u2014current status","volume":"4","author":"Waxman","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.jns.2009.04.023_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF03033568","article-title":"Glutamate antagonists are neurotoxins for the developing brain","volume":"11","author":"Kaindl","year":"2007","journal-title":"Neurotox Res"},{"key":"10.1016\/j.jns.2009.04.023_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2006.06.022","article-title":"New targets for pharmacological intervention in the glutamatergic synapse","volume":"545","author":"Gardoni","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2009.04.023_bib37","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI32796","article-title":"Estrogen receptor beta protects against acoustic trauma in mice","volume":"118","author":"Meltser","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2009.04.023_bib38","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1523\/JNEUROSCI.2588-07.2007","article-title":"Estradiol improves cerebellar memory formation by activating estrogen receptor beta","volume":"27","author":"Andreescu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2009.04.023_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pbb.2006.07.003","article-title":"Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats","volume":"86","author":"Walf","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jns.2009.04.023_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tins.2008.07.003","article-title":"The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications","volume":"31","author":"Brinton","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2009.04.023_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroscience.2004.11.054","article-title":"17beta-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism","volume":"132","author":"Zhao","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2009.04.023_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.22023","article-title":"17beta-estradiol protects against hypoxic\/ischemic white matter damage in the neonatal rat brain","author":"Gerstner","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2009.04.023_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000082141","article-title":"Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones","volume":"26","author":"Marin-Husstege","year":"2004","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.jns.2009.04.023_bib44","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.4049\/jimmunol.171.11.6267","article-title":"Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol","volume":"171","author":"Soldan","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2009.04.023_bib45","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1210\/en.2006-0113","article-title":"Quantitative structure\u2013activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: insights into the structural determinants favoring a differential subtype binding","volume":"147","author":"Zhu","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.jns.2009.04.023_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/107385840100700310","article-title":"Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"7","author":"Voskuhl","year":"2001","journal-title":"Neuroscientist"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09005620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09005620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T02:11:49Z","timestamp":1558318309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09005620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0022510X09005620"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.04.023","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}